Emerging importance of ALK in neuroblastoma
- 16 September 2011
- journal article
- review article
- Published by Elsevier BV in Seminars in Cancer Biology
- Vol. 21 (4), 267-275
- https://doi.org/10.1016/j.semcancer.2011.09.005
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALKMolecular Therapy, 2011
- Discovery of 3,5-Diamino-1,2,4-triazole Ureas as Potent Anaplastic Lymphoma Kinase InhibitorsACS Medicinal Chemistry Letters, 2011
- Inhibition of ALK, PI3K/MEK, and HSP90 in Murine Lung Adenocarcinoma Induced by EML4-ALK Fusion OncogeneCancer Research, 2010
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Anaplastic lymphoma kinase: signalling in development and diseaseBiochemical Journal, 2009
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastomaNature, 2008
- Activating mutations in ALK provide a therapeutic target in neuroblastomaNature, 2008
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALKProceedings of the National Academy of Sciences, 2007
- Anaplastic Lymphoma Kinase Is a Dependence Receptor Whose Proapoptotic Functions Are Activated by Caspase CleavageMolecular and Cellular Biology, 2006